Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome

References

• Diamanti-Kandarakis E, Kouli C R, Bergiele A T, Filandra F A, Tsianateli T C, Spina G G, Zapanti E D, Bartzis M I. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006–4011
   PubMed Web of Science ®Google Scholar
• Azziz R, Woods K S, Reyna R, Key T J, Knochenhauer E S, Yildiz B O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745–2749
   PubMed Web of Science ®Google Scholar
• Dunaif A, Segal K R, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165–1174
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanisms and implication for pathogenesis. Endocr Rev 1997; 18: 774–800
   PubMed Web of Science ®Google Scholar
• Wild R A, Painter P C, Coulson P B, Carruth K B, Ranney G B. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985; 61: 946–951
   PubMed Web of Science ®Google Scholar
• Legro R S, Kunselman A R, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001; 111: 607–613
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Papavassiliou A G, Kandarakis S A, Chrousos G P. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 2007; 18: 280–285
   PubMed Web of Science ®Google Scholar
• Berneis K, Rizzo M, Fruzzetti F, Lazzarini V, Carmina E. Atherogenic lipoprotein phenotype and low density lipoproteins size and subclasses in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92: 186–189
   PubMed Web of Science ®Google Scholar
• Shaw L J, Bairey C N, Azziz R, Stanczyk F Z, Sopko G, Braunstein G D, Kelsey S F, Kip K E, Cooper-Dehoff R M, Johnson B D, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the national institutes of health-national heart, lung, and blood institute sponsored women's ischemia syndrome. Evaluation. J Clin Endocrinol Metab 2008; 93: 1276–1284
   PubMed Web of Science ®Google Scholar
• Solomon C G, Hu F B, Dunaif A, Rich-Edwards J, Willett W C, Hunter D J, Colditz G A, Speizer F E, Manson J E. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 2001; 286: 2421–2426
   PubMed Web of Science ®Google Scholar
• Glueck C J, Morrison J A, Friedman L A, Goldenberg N, Stroop D M, Wang P. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabolism 2006; 55: 508–514
   PubMed Web of Science ®Google Scholar
• Demirel F, Bideci A, Cinaz P, Camurdan M O, Biberoğlu G, Yesilkaya E, Hasanoglu A. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2007; 67: 129–134
   PubMed Web of Science ®Google Scholar
• Vryonidou A, Papatheodorou A, Tavridou A, Terzi T, Loi V, Vatalas I A, Batakis N, Phenekos C, Dionyssiou-Asteriou A. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 2740–2746
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, Perini D, Lazzarini V, Parrini D, Genazzani A R. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril Aug 13, 2008
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 2007; 18: 774–800
   Google Scholar
• Grundy S M. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999; 83: 25–29
   PubMed Web of Science ®Google Scholar
• Haffner S M, Valdez R A, Hazuda H P, Mitchell B D, Morales P A, Stern M P. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715–722
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen M R, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689
   PubMed Web of Science ®Google Scholar
• Trevisan M, Liu J, Bahsas F B, Menotti A. Syndrome X and mortality: a population-based study. Risk factor and life expectancy research group. Am J Epidemiol 1998; 48: 958–966
   Google Scholar
• Haffner S M, D'Agostino R, Jr, Festa A, Bergman R N, Karter A, Saad M F, Wagenknecht L E. Low insulin sensitivity in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors. Diabetes Care 2003; 26: 2796–2803
   PubMed Web of Science ®Google Scholar
• Apridonidze T, Essah P A, Iuorno M J, Nestler J E. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 1929–1935
   PubMed Web of Science ®Google Scholar
• Glueck C J, Papanna R, Wang P, Goldenberg N, Sieve-Smith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism 2003; 52: 908–915
   PubMed Web of Science ®Google Scholar
• Dokras A, Bochner M, Hollinrake E, Markham S, Vanvoorhis B, Jagasia D H. Screening women with polycystic syndrome for metabolic syndrome. Obstet Gynecol 2005; 106: 131–137
   PubMed Web of Science ®Google Scholar
• Essah P A, Nestler J E. The metabolic syndrome in polycystic ovary syndrome. J Clin Invest 2006; 29: 270–280
   Google Scholar
• Coviello A D, Legro R S, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006; 91: 492–497
   PubMed Web of Science ®Google Scholar
• Zawadski J K, Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. Polycystic ovary syndrome, A Dunaif, J R Givens, F Haseltine. Blackwell Scientific, Boston 1992; 377–384
   Google Scholar
• The Rotterdam ESHRE/ASRM-sponsored PCOS consensus Workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Sterl 2004; 81: 19–25
   Web of Science ®Google Scholar
• Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 2006; 29: 581–593
   PubMed Web of Science ®Google Scholar
• Fernández J R, Redden D T, Pietrobelli A, Allison D B. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004; 145: 439–444
   PubMed Web of Science ®Google Scholar
• Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insuline resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentrations of low density lipoprotein cholesterol without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• de Ferranti S D, Gauvreau K, Ludwig D S, Neufeld E J, Newburger J W, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the third national health and nutrition examination survey. Circulation 2004; 110: 2494–2497
   PubMed Web of Science ®Google Scholar
• National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555–576
   PubMed Web of Science ®Google Scholar
• Apter D, Vihko R. Premenarcheal endocrine changes in relation to age at menarche. Clin Endocrinol, 22: 753–760
   PubMed Web of Science ®Google Scholar
• Venturoli S, Porcu E, Fabbri R, Magrini O, Paradisi R, Pallotti G, Gammi L, Flamigni C. Postmenarchal evolution of endocrine pattern and ovarian aspects in adolescents with menstrual irregularities. Fertil Steril 1987; 48: 78–85
   PubMed Web of Science ®Google Scholar
• Pasquali R, Gambineri A. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Ann N Y Acad Sci 2006; 1092: 158–174, Review
   PubMed Web of Science ®Google Scholar
• Jeffrey Chang R, Coffler M S. Polycystic ovary syndrome: early detection in the adolescent. Clin Obstet Gynecol 2007; 50: 178–187
   PubMed Web of Science ®Google Scholar
• Rosenfield R L. Clinical review: identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92: 787–796
   PubMed Web of Science ®Google Scholar
• Cook S, Weitzman M, Auinger P, Nguyen M, Dietz W H. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 2003; 157: 821–827
   PubMed Web of Science ®Google Scholar
• Weiss R, Dziura J, Burgert T S, Tamborlane W V, Taksali S E, Yeckel C W, Allen K, Lopes M, Savoye M, Morrison J, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362–2374
   PubMed Web of Science ®Google Scholar
• Cruz M L, Weigensberg M J, Huang T T, Ball G, Shaibi G Q, Goran M I. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004; 89: 108–113
   PubMed Web of Science ®Google Scholar
• Frontini M G, Srinivasan S R, Berenson G S. Longitudinal changes in risk variables underlying metabolic syndrome X from childhood to young adulthood in female subjects with a history of early menarche: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2003; 27: 1398–1404
   PubMed Web of Science ®Google Scholar
• Goodman E, Daniels S R, Morrison J A, Huang B, Dolan L M. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr 2004; 145: 445–451
   PubMed Web of Science ®Google Scholar
• Carmina E, Napoli N, Longo R A, Rini G B, Lobo R. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol 2006; 154: 141–145
   PubMed Web of Science ®Google Scholar
• Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod 2005; 20: 2409–2413
   PubMed Web of Science ®Google Scholar
• Carmina E, Chu M C, Longo A, Rini G B, Lobo R. Phenotypic variations in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 2005; 90: 2545–2549
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Papavassiliou A G, Kandarakis S A, Chrousos G P. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 2007; 18: 280–285
   PubMed Web of Science ®Google Scholar
• Holte J, Gennarelli G, Berne C, Bergh T, Lithell H. Elevated ambulatoryday-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state. Hum Reprod 2003; 11: 23–28
   Google Scholar
• Mei-Jou C, Wei-Shiung Y, Jehn-Hsiahn Y, Chi-Ling, Hong-Nerng H, Yu-Shih Y. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension 2007; 49: 1442–1447
   PubMed Web of Science ®Google Scholar